CClinicalTrials.gg
RecruitingNCT07507747Peer mHealthUpdated Oct 2, 2026

Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Care Veterans With Psychological Distress

An interventional study of Self Managed mHealth and 1 session of peer mHealth in Psychological Distress, sponsored by VA Office of Research and Development. Recruiting at 5 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Updated Oct 2, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
384
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Many Veterans experience psychological distress including depression, post-traumatic stress disorder (PTSD), anxiety and problems with sleep and anger. Services to address these problems need to be easy for Veterans to access. VA mobile health applications (mHealth apps) that teach skills to manage psychological distress are widely available. However, Veterans rarely use these apps enough to experience health benefits. Peer specialists are VA employees who are trained to use their lived experiences in mental health recovery to help other Veterans. Peers can provide support and accountability to Veterans as they use mHealth apps. Peers working in VA primary care settings are easily accessible to Veterans who receive VA services. This study aims to improve the health of Veterans by testing the effectiveness of peer-supported mHealth in reducing psychological distress. It will also test how much peer support Veterans need to improve their health with using mHealth apps.

Read the detailed description

Background: Psychological distress in Veterans Affairs (VA) primary care patients is common and often not adequately treated. The VA has a suite of evidence-informed mobile health applications (mHealth apps) for psychological distress that are frequently downloaded, but most Veterans do not use them enough to experience health benefits. Support from helping professionals, such as peer specialists, can increase app use and health benefits. The study team found that peer-supported mHealth is feasible to deliver in VA primary care, increases app engagement and is associated with high satisfaction and improved Veteran health. However, not all individuals need the same amount of support when using mHealth. This study will test an adaptive intervention using a SMART design to match patient need with specific doses of peer support for mHealth.

Significance: The long-term goal is to improve the health of Veterans with psychological distress by developing a brief and efficient stepped-care intervention that can be feasibly implemented in VA primary care settings. This proposal is highly aligned with the priorities of the operational partners in the Offices of Mental Health and Patient Centered Care \& Cultural Transformation and VA BBMH. The findings will support the VA-wide expansion of the Peers in PACT program, per recent STRONG Act legislation.

Innovation \& Impact: Key innovations include the use of a SMART design to develop an adaptive intervention for a high-priority patient population and the novel application of the Supportive Accountability model in which human support is critical to enhancing adherence to mHealth interventions. The proposal will also provide much needed data on the effectiveness of peers to deliver brief, structured interventions.

Specific Aims: 1) Test the effectiveness of a) stage 1 (Peer mHealth vs. Self-Managed mHealth), b) stage 2 interventions (4 sessions of Peer mHealth vs. Peer Whole Health) among slow responders and c) the embedded stepped-care treatment sequences on psychological distress and secondary outcomes (e.g., app use, cost, mental health service use, symptoms, functioning) at 12 weeks. 2) Examine candidate tailoring variables as predictors of outcomes in a) stage 1 (i.e., motivation, coping self-efficacy) and b) stage 2 (i.e., app use and unmet social needs). Race/ethnicity and sex/gender will also be explored as moderators. 3) Assess barriers and facilitators to implementing adaptive interventions for peer mHealth in PACT by interviewing key VHA leadership, staff and Veteran stakeholders.

Methodology: Participants (N=384) with significant psychological distress who are not engaged in specialty mental health care will be randomized at Stage 1 to receive either Self-Managed mHealth or one peer phone call to support mHealth. Participant response, defined as a reliable decrease in psychological distress (5-point decrease in any DASS-21 subscale) will be measured after 4 weeks. Stage 2 randomization will assign slow responders to step-up to additional mHealth peer phone calls or an alternative peer support model (peer-delivered Whole Health). Stage 1 early responders will continue/ step-down to Self-Managed mHealth. All participants will be reassessed at 12, 16 and 24 weeks post-enrollment. Psychological distress is the primary outcome. Secondary outcomes include app use, mental health service use, cost, psychological symptoms (e.g., depression, anxiety, stress, PTSD, anger, sleep), and functioning (e.g., social functioning).

Next Steps/ Implementation: Should these results support the effectiveness of the adaptive intervention, the investigators will disseminate peer training through the Peers in PACT and Tech into Care VA networks. The investigators will also prepare a new ORD application to systemically investigate how the adaptive intervention can be implemented in VA.

02

Conditions studied

  • Psychological Distress

Keywords

  • peer support
  • mHealth
  • Veterans
  • SMART design
  • psychological distress
03

In context

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Veteran enrolled in primary care at one of 3 VA facilities (Philadelphia, PA; Ann Arbor, MI; and Bedford, MA)
  • clinically significant psychological distress on at least one DASS-21 subscale (Depression => 10, Anxiety => 8, Stress => 13)

Exclusion criteria

Exclusion Criteria:

  • symptoms that may preclude active engagement in the intervention such as gross cognitive impairment or current symptoms of mania or psychosis
  • suicide risk as measured by the P4 Suicide Assessment
  • plan to engage in psychotherapy during the intervention period
  • started or changed the dose of a psychotropic medication in the last two months
  • voice a preference to be directly referred to mental health specialty care
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
384 participants (estimated)

Study arms

  • Experimental
    Stage 1

    Stage 1 randomization

    Behavioral: Self Managed mHealth · Behavioral: 1 session of peer mHealth

  • Experimental
    Stage 2

    Stage 2 randomization

    Behavioral: Self Managed mHealth · Behavioral: 4 sessions Peer mHealth · Behavioral: 4 sessions of Peer Whole Health

Interventions

  • BehavioralSelf Managed mHealth

    Patients use mHealth apps to manage psychological distress

  • Behavioral1 session of peer mHealth

    Patients receive one session with a peer while using mHealth apps to manage psychological distress

  • Behavioral4 sessions Peer mHealth

    Patients receive 4 sessions with a peer while using mHealth apps to manage psychological distress

  • Behavioral4 sessions of Peer Whole Health

    Patients receive 4 session with a peer focused on Whole Health

06

What researchers measure

Primary outcomes

  1. Depression Anxiety and Stress Scale

    Depression Anxiety and Stress Scale is a widely used measure of psychological distress consisting of 21 items measured on a 4-point scale. The total score ranges from 0-63. Higher scores indicate greater severity.

    Time frame: baseline to 24 weeks

Secondary outcomes

  1. Post Traumatic Stess Checklist-5

    Self report measure assessing the 21 symptoms of post-traumatic stress disorder (PTSD) on a 5 point scale. Total score ranges from 0-105. Higher scores indicate greater severity.

    Time frame: baseline to 24 weeks

  2. Insomnia Severity Index

    Self report measure assessing insomnia with 7 questions on a 5 point scale. Total score range from 0-28. Higher scores indicate greater severity.

    Time frame: baseline to 25 weeks

  3. Dimensions of Anger Reactions

    Self report measure assessing anger with 5 items on a 5 point scale. Total score ranges from 5-25. Higher scores indicate greater severity.

    Time frame: baseline to 24 weeks

  4. Brief Inventory of Psychosocial Functioning

    Self report measure of psychosocial functioning measured with 7 items on 7 point scale. Total ranges from 0-42. Higher scores indicate more dysfunction.

    Time frame: baseline to 24 weeks

  5. Satisfaction with Life Questionnaire

    Self report measure assessing life satisfaction with 5 items on an eight point scale. Total score ranges from 5-35. High scores indicate greater satisfaction.

    Time frame: baseline to 24 weeks

  6. Client Satisfaction Questionnaire

    Self report measure assessing participant satisfaction with study interventions with 8 items measures on a 4 point scale. Total score ranges from 0-24. Higher scores indicate greater satisfaction.

    Time frame: baseline to 24 weeks

Other outcomes

  1. University of Rhode Island Change Assessment

    Self report measure assessing patient motivation to address psychological distress with 12 items on a 5 point scale. Total score ranges from 12 to 60. Higher scores indicate more motivation.

    Time frame: baseline to 24 weeks

  2. Coping Self Efficacy Scale

    Self report measure to assess patient self efficacy to address psychological distress with 26 items on a 11 point scale. Total score ranges from 0-260 with higher scores indicating greater self-efficacy.

    Time frame: baseline to 24 weeks

  3. Assessing Circumstances and Offering Resources for Needs

    Measure of unmet social needs that include 11 questions. The total score ranges from 0-48 with higher scores indicating more unmet needs.

    Time frame: baseline to 24 weeks

07

Study locations

1 of 5 sites recruiting
  • VA Palo Alto Health Care System, Palo Alto, CA
    Palo Alto, California 94304-1207, United States
    Not yet recruiting
  • VA Bedford HealthCare System, Bedford, MA
    Bedford, Massachusetts 01730-1114, United States
    Not yet recruiting
  • VA Ann Arbor Healthcare System, Ann Arbor, MI
    Ann Arbor, Michigan 48105-2303, United States
    Not yet recruiting
  • Syracuse VA Medical Center, Syracuse, NY
    Syracuse, New York 13210-2716, United States
    • Kyle Possemato, PhD · Contact · kyle.possemato@va.gov · (315) 425-4400
    • Kyle Possemato, PhD · Principal investigator
    Recruiting
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
    Philadelphia, Pennsylvania 19104-4551, United States
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Oct 2, 2026
Sites
5 sites changed recruiting status
Oct 2, 2026
Start date
Oct 1, 2026→Sep 27, 2026 (actual)
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Not yet recruiting→Recruiting
    5 sites changed recruiting status
    Start date Oct 1, 2026→Sep 27, 2026 (now actual)
    + 2 other changes: description and secondary outcomes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07507747
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Apr 2, 2026
Start date
Sep 27, 2026
Primary completion
Apr 30, 2029 (estimated)
Completion
Apr 30, 2030 (estimated)
Last update
Oct 2, 2026

Study contacts

Kyle Possemato, PhD
Contact
kyle.possemato@va.gov
(315) 425-4400 ext. 53551
Kyle Possemato, PhD
principal investigator · Syracuse VA Medical Center, Syracuse, NY

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion